Mekonos closes $25M funding round for cell therapy platform

Mekonos closes funding of $25M in a series a round as it develops the future of cell therapies on a chip. The...

Novartis subsidiary Sandoz increasing its antibiotics manufacturing capacity in Europe with $183m investment

Sandoz, a Novartis company , is planning to invest $183 million (€150 million) in Kundl, Spain, Austria, and Palafolls to expand its antibiotic production network in Europe.

Latest news

Avillion and AstraZeneca combination medicine presents positive results for people living with asthma 

The New England Journal of Medicine has published the results of Avillion and AstraZeneca’s PT027 after participation...
- Advertisement -

Orion signs $16 million deal with Jemincare for development of novel non-opioid pain treatment

The deal involves a $16 million payment from Orion to Jemincare with milestones as well as royalty...

Several drug recalls hit the US market, including Pfizer’s Accupril

Leading pharmaceutical companies have been hit by recalls recently. These U.S. based drugs  include Jubilant’s Methylprednisolone ,...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC